Search Results for: RBPMS

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
FAM168A family with sequence similarity 168 member A
FASTK Fas activated serine/threonine kinase
FBF1 Fas binding factor 1
  • Anchoring of the basal body to the plasma membrane
FBXL18 F-box and leucine rich repeat protein 18
  • FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
FNDC11 fibronectin type III domain containing 11
FOXC2 forkhead box C2
  • Formation of intermediate mesoderm
  • Formation of the ureteric bud
  • Lymphedemas, including: Lymphedema, hereditary I; Lymphedema-distichiasis syndrome (LD); Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS)
FOXP3 forkhead box P3
  • RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
  • RUNX1 regulates transcription of genes involved in WNT signaling
  • Permanent neonatal diabetes mellitus (PNDM)
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
FOXS1 forkhead box S1
FRG1 FSHD region gene 1
FXR2 FMR1 autosomal homolog 2
GATA1 GATA binding protein 1
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Factors involved in megakaryocyte development and platelet production
  • Congenital dyserythropoietic anemias (CDAs)
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
GATA2 GATA binding protein 2
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Transcriptional regulation of granulopoiesis
  • Factors involved in megakaryocyte development and platelet production
GATAD2B GATA zinc finger domain containing 2B
  • HDACs deacetylate histones
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • Regulation of TP53 Activity through Acetylation
  • RNA Polymerase I Transcription Initiation
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Potential therapeutics for SARS
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
GCM2 glial cells missing transcription factor 2
GLIS2 GLIS family zinc finger 2
  • Nephronophthisis-medullary cystic kidney disease, including; Nephronophthisis (NPH) ; Nephronophthisis-like nephropathy 1; Medullary cystic kidney disease 1; Medullary cystic kidney disease 2 (MSKD2)
GLYCTK glycerate kinase
  • Fructose catabolism
GPATCH2L G-patch domain containing 2 like
GPS2 G protein pathway suppressor 2
  • PPARA activates gene expression
  • HDACs deacetylate histones
  • Loss of MECP2 binding ability to the NCoR/SMRT complex
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • HCMV Early Events
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
GRAP GRB2 related adaptor protein
  • Signaling by SCF-KIT
GRAP2 GRB2 related adaptor protein 2
  • Signaling by SCF-KIT
  • Generation of second messenger molecules
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Co-stimulation by CD28
  • FLT3 Signaling
  • Signaling by CSF1 (M-CSF) in myeloid cells

Page 5 out of 16 pages